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Hypothesis / aims of study 
This study compares inhibition of mast cell degranulation between panels of honey 
preparations and conventional topical treatments used against painful bladder syndrome/ 
interstitial cystitis (PBS/IC). 
The hypothesis underpinning these experiments is that the anti-inflammatory action of honey 
is different from that of the conventional agents, offering the possibility of alternative or 
combination treatments for PBS/IC. 
 
Study design, materials and methods 
The study builds on firm results in preparation for publication, that show various honey types 
to inhibit calcium ionophore-induced degranulation of the human mast cell line ‘LAD-2’ [1]. 
Histamine release, both spontaneous and stimulated by calcium ionophore A23187, was 
measured by a commercial ELISA assay. Concentrations of honeys that demonstrate 
inhibition of histamine release from stimulated LAD-2 cells were compared with conventional 
agents, diluted serially from their intravesical therapeutic concentrations.   
 
Results 
Histamine release from LAD-2 cells is inhibited in a dose-dependent fashion by honey (fig.1), 
both spontaneously and when stimulated by calcium ionophore A23187. Honeys derived from 
a range of nectars show different activities in this respect (fig.2). By comparison, few of the 
conventional PBS/IC treatment drugs showed any inhibition, none were strong inhibitors and 
some increased histamine recovery (fig.3). 
 
Interpretation of results 
The results presented above demonstrate that honey can have a strong inhibitory effect on 
degranulation of the LAD-2 cell line, as evidenced by histamine release. Eucalyptus-based 
honey appeared particularly effective in this model. None of the panel of conventional 
intravesical agents was as effective; most were completely inactive in this model.  
 
Given that PBS/IC is an essentially inflammatory process and that mastocytosis in the bladder 
wall has been used to diagnose the condition [2], it is reasonable to suppose that honey 
preparations might be a useful additional tool in the clinical management of PBS/IC.   
 
In-vitro studies from this group exposing rodent urothelium to honey dilutions have provided 
evidence that honey might be well tolerated as an intravesical agent and even provide some 
protection against chemical (acid) damage [3]. 
 
Concluding message 
Honey has strong potential as an intravesical agent for the treatment of PBS/IC.  Its activity 
against mast cell degranulation is not represented in current treatments and promises an 
additive effect in combination therapy.  In-vivo studies of intravesical tolerability in intact 
rodents and humans (i.e. phase-I trial), including bladders with compromised urothelial 
linings, are warranted. 
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Dose-dependent inhibition of mast cell histamine release by calcium ionophore A23187using 
four honey concentrations (n=4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.2  
Percent inhibition of induced histamine release by different honey types (n=8):  Clover nectar 
and ‘artificial’ honey (a glucose fructose syrup) are control preparations.  ‘Manuka 02’ is an 
aged honey. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 
Percent inhibition of calcium ionophore induced histamine release using 2 honey 
concentrations and 3 dilutions (from clinical intravesical concentrations) of common PBS/IC 
drugs (n=4).  RIMSO-50 is dimethyl sulfoxide with a probable anti-inflammatory action, the 
other drugs target deficiencies in the glycosoaminoglycans layer lining the bladder lumen. 
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